test

Aryn Sands

@Privium Fund Management B.v.

Latest period2024 - Q3ReportedManaged Assets$402.033MTotal holdings82
Assets growth rate2.54%Assets growth rate (2-Q avg)3.63%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Privium Fund Management B.v.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 82 positions.

Assets under management

The assets under management (AUM) of Privium Fund Management B.v. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 402.033M in assets, with a quarterly growth rate of 2.54% and a 2-quarter average growth rate of 3.63%. The portfolio is managed by Aryn Sands, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IONSIonis Pharmaceuticals Inc
Recent Activity
Increased 1.41%
2.5%
$10.045M
250,744 shares@ $40.06 avg price
NVDANvidia Corporation
Recent Activity
Increased 28.08%
2.21%
$8.864M
73,000 shares@ $121.44 avg price
ITCIIntra-cellular Therapies Inc
Recent Activity
2.15%
$8.633M
117,983 shares@ $73.17 avg price
DDOGDatadog Inc
Recent Activity
1.89%
$7.567M
65,993 shares@ $114.66 avg price
AMDAdvanced Micro Devices Inc
Recent Activity
Increased 18.92%
1.8%
$7.225M
44,000 shares@ $164.21 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Increased 7.94%
1.8%
$7.21M
80,232 shares@ $89.88 avg price
MRKMerck & Co Inc
Recent Activity
Increased 37.25%
1.7%
$6.826M
60,111 shares@ $113.56 avg price
GOOGLAlphabet Inc
Recent Activity
1.66%
$6.634M
40,000 shares@ $165.85 avg price
ARWRArrowhead Pharmaceuticals In
Recent Activity
Increased 16.18%
1.61%
$6.457M
333,356 shares@ $19.38 avg price
ROIVRoivant Sciences Ltd
Recent Activity
1.4%
$5.591M
484,500 shares@ $11.54 avg price